A recent study published in the journal JAMA evaluated the efficacy and side effects of donanemab. They aimed to use this antibody to clear brain amyloid plaque in randomized participants with early symptomatic Alzheimer disease (AD) with low/medium or high tau pathology.
Read more “Donanemab: A trailblazer for Alzheimer’s disease treatment?”
Doctors urge more research on the use of psilocybin and other psychedelics for women’s cancer distress
It’s time to stop prevaricating and explore the use of psilocybin—the active ingredient in ‘magic mushrooms’—and other psychedelics to ease the often overwhelming distress faced by women with late stage gynecological cancers, urge doctors in a commentary published online in the International Journal of Gynecological Cancer.
Read more “Doctors urge more research on the use of psilocybin and other psychedelics”
Data scientists at the Icahn School of Medicine at Mount Sinai in New York and colleagues have created an artificial intelligence model that may more accurately predict which existing medicines, not currently classified as harmful, may in fact lead to congenital disabilities.
Read more “AI model accurately predicts which drugs may cause birth defects”
ChatGPT may be the fastest-growing consumer internet application to have ever been launched. Launched in November, the artificial intelligence (AI) chatbot developed by OpenAI reached 100 million users in just two months. Its unprecedented popularity can be attributed to its impressive capabilities. The man who ignited the home computer revolution, Bill Gates, believes ChatGPT will ‘change the world,’ claiming that AI is just as important as the PC and the internet.
A 58-year-old female has a history of depression and reports to you that she forgot her paroxetine when she went on vacation. She has missed one dose and is asking you how many more she can miss before getting the medication again. Her current dosing is 40 mg daily. What are some things to think about with this paroxetine missed doses case scenario?
